2i47: Difference between revisions

@@ Line 1: / Line 1: @@
-[[Image:2i47.gif|left|200px]]
+{{Seed}}
+[[Image:2i47.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2i47|  PDB=2i47  |  SCENE=  }}
-'''Crystal structure of catalytic domain of TACE with inhibitor'''
+===Crystal structure of catalytic domain of TACE with inhibitor===
-==Overview==
+<!--
-By focusing on the P1 portion of the piperidine beta-sulfone ligands we identified a motif that induces selectivity and resulted in a series of TACE inhibitors that demonstrated excellent in vitro potency against isolated TACE enzyme and excellent selectivity over MMPs 1, 2, 9, 13, and 14.
+The line below this paragraph, {{ABSTRACT_PUBMED_17064892}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 17064892 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_17064892}}
 ==About this Structure==
@@ Line 28: / Line 32: @@
 [[Category: Tace-inhibitor complex]]
 [[Category: Tace/adam-17]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 07:02:50 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 11:17:29 2008''

Navigation menu